arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

CNBX Pharmaceuticals Inc.

CNBX

— Price unavailable

21 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bullish

auto_awesome

Analytical Summary

CNBX Pharmaceuticals Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth N/M

Op. Margin None

ROIC 8.6% ↘

FCF / Share $-0.00 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

21-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-313.98K

↑ +54.8% —

Operating Margin Operating profit as % of sales

-448.3%

↓ -97.4% —

FCF / Share Free cash flow per share

$-0.00

↑ +76.6% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Aug 31, 2025 10-K ↗	FY 2024 Aug 31, 2024 10-K ↗	FY 2023 Aug 31, 2023 10-K ↗	FY 2022 Aug 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2006 Aug 31, 2006 10-K ↗	FY 2005 Aug 31, 2005 10-K ↗
Revenue Growth YoY (%)	N/M	-68.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-954%)	1269.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15764%)	—	—	-27.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-441%)	2.5% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-68%)	68.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+761%)	-94.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1287%)	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	100.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	95.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	88.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-17850.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	54.8% Excellent ↑ Excellent Improving Year-over-year change in net income	81.3% Excellent ↑ Excellent Improving Year-over-year change in net income	0.3% Caution ↓ Caution Declining Year-over-year change in net income	-16.6% Weak Weak Year-over-year change in net income	57.2% Excellent Excellent Year-over-year change in net income	N/M	N/M	-95.3% Weak ↑ Weak Improving Year-over-year change in net income	-21.9% Weak ↑ Weak Improving Year-over-year change in net income	-24.0% Weak ↑ Weak Improving Year-over-year change in net income	-373.7% Weak ↓ Weak Declining Year-over-year change in net income	-378.7% Weak ↓ Weak Declining Year-over-year change in net income	86.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-0.4% Weak ↑ Weak Improving Year-over-year change in net income	-256.3% Weak ↓ Weak Declining Year-over-year change in net income	-0.1% Weak ↑ Weak Improving Year-over-year change in net income	-318.5% Weak ↑ Weak Improving Year-over-year change in net income	-18.3% Weak ↑ Weak Improving Year-over-year change in net income	-15.9% Weak Weak Year-over-year change in net income	-1012.3% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	76.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	36.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	99.1% Excellent Excellent Year-over-year change in free cash flow	-7531.4% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	285.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	44.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	—	8.0% Fair Fair Compound annual revenue growth over 3 years	-55.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	67.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	111.9% Excellent Excellent Compound annual revenue growth over 5 years	39.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Aug 31, 2025 10-K ↗	FY 2024 Aug 31, 2024 10-K ↗	FY 2023 Aug 31, 2023 10-K ↗	FY 2022 Aug 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2006 Aug 31, 2006 10-K ↗	FY 2005 Aug 31, 2005 10-K ↗
Operating Margin (%) (%)	—	-448.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3089%)	-227.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1614%)	—	—	—	—	—	—	-249.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1763%)	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	-187.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-27.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	-106.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.55x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.03x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-2.73x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.08x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.39x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.05x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Aug 31, 2025 10-K ↗	FY 2024 Aug 31, 2024 10-K ↗	FY 2023 Aug 31, 2023 10-K ↗	FY 2022 Aug 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2006 Aug 31, 2006 10-K ↗	FY 2005 Aug 31, 2005 10-K ↗
Return on Invested Capital (%)	8.6% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	18.6% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	36.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	143.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-113.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-136.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-113.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	47.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	174.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-539.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	55.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-1473.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1858.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-186.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-364.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-84.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-137.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-119.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1183.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1879.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-189.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-79.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	12.6% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-16%)	28.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+87%)	183.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1126%)	228.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1421%)	-176.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1279%)	—	7.7% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-49%)	-142.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1052%)	-65.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-539%)	—	—	—	53.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+257%)	—	—	-191.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1378%)	-65.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-538%)	-9.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	-7.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-13.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	140.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+838%)

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Aug 31, 2025 10-K ↗	FY 2024 Aug 31, 2024 10-K ↗	FY 2023 Aug 31, 2023 10-K ↗	FY 2022 Aug 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2006 Aug 31, 2006 10-K ↗	FY 2005 Aug 31, 2005 10-K ↗
Interest Coverage (x)	-6.82x Weak Weak Operating income divided by interest expense Optimal: > 5x	-34.71x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	-180.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-423.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-39.10x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-178.30x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-222.59x Weak Weak Operating income divided by interest expense Optimal: > 5x	-324.64x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—
Net Debt (USD)	$-15.11K	$-26.42K	$-129.70K	$-117.52K	$-1.39M	$-777.61K	$-265.98K	$-1.39M	$-3.37M	$-19.13K	$-25.23K	$-98.77K	$-72.75K	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Aug 31, 2025 10-K ↗	FY 2024 Aug 31, 2024 10-K ↗	FY 2023 Aug 31, 2023 10-K ↗	FY 2022 Aug 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2006 Aug 31, 2006 10-K ↗	FY 2005 Aug 31, 2005 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	$0.05	$0.02	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.00	$-0.02	$-0.42	$-3.59	$-0.02	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.00	$-0.01	$-0.01	$-1.37	$-0.02	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.00	$-0.08	$-0.09	$-1.32	$0.01	$0.01	$0.11	$0.02	$0.02	$-0.00	$-0.00	$0.00	$-0.08	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$-0.00	$-0.08	$-0.09	$-1.32	$0.01	$0.01	$0.11	$0.02	$0.02	$-0.00	$-0.00	$0.00	$-0.08	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	90.65M	30.25M	8.82M	1.22M	138.52M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Aug 31, 2025 10-K ↗	FY 2024 Aug 31, 2024 10-K ↗	FY 2023 Aug 31, 2023 10-K ↗	FY 2022 Aug 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2006 Aug 31, 2006 10-K ↗	FY 2005 Aug 31, 2005 10-K ↗
Working Capital (USD)	$-2.50M	$-2.48M	$-2.29M	$-2.25M	$317.80K	$475.12K	$3.87M	$1.08M	$2.82M	$-469.07K	$-312.83K	$38.62K	$-105.39K	—	—	—	—	—	—	—	—
Total Equity (USD)	$-2.50M	$-2.48M	$-2.02M	$-1.63M	$1.81M	$1.76M	$14.74M	$2.65M	$2.94M	$-467.45K	$-309.63K	$40.08K	$-105.39K	$-48.99K	$-47.34K	$59.97K	$174.95K	$289.87K	$317.33K	$144.45K	$-1.28K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Aug 31, 2025 10-K ↗	FY 2024 Aug 31, 2024 10-K ↗	FY 2023 Aug 31, 2023 10-K ↗	FY 2022 Aug 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 31, 2012 10-K ↗	FY 2011 Aug 31, 2011 10-K ↗	FY 2010 Aug 31, 2010 10-K ↗	FY 2009 Aug 31, 2009 10-K ↗	FY 2008 Aug 31, 2008 10-K ↗	FY 2007 Aug 31, 2007 10-K ↗	FY 2006 Aug 31, 2006 10-K ↗	FY 2005 Aug 31, 2005 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$130.07K	$410.17K	$29.96K	—	$7.16K	$9.84K	$9.60K	$5.68K	$112.50K	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$0.00	$72.32K	$162.06K	$198.53K	$220.93K	$215.16K	$188.93K	$88.44K	$7.02K	$1.58K	$1.30K	$86.00	$0.00	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-313.98K	$-695.20K	$-3.71M	$-3.72M	$-3.19M	$-7.47M	$1.13M	$-3.78M	$-1.93M	$-1.59M	$-1.28M	$-270.00K	$-56.40K	$-411.35K	$-409.69K	$-114.98K	$-114.92K	$-27.46K	$-23.20K	$-20.02K	$-1.80K
Operating Cash Flow (USD)	$-171.31K	$-244.27K	$-112.52K	$-1.68M	$-2.49M	$-2.77M	$-3.09M	$-1.97M	$-863.57K	$-120.10K	—	—	—	$-161.11K	$-161.11K	$6.00K	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 21 years · 70 quarters

CNBX Pharmaceuticals Inc.

Analytical Summary

21-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CNBX with peers